The American Society of Hematology (ASH) has announced the appointment of Dr. Jorge Cortes to serve as the inaugural editor-in-chief of the newest addition to the Blood journals portfolio: Blood Global Hematology. He was selected after a competitive international search.
Blood Global Hematology will be a peer-reviewed, open access journal focusing on the publication of high-quality original articles describing basic laboratory, translational, and clinical investigations in hematology research that address issues of global reach or with a global focus. The journal will also publish local adaptations of clinical guidelines, epidemiology, and public health analyses, opinion articles, and prospective studies evaluating locally available treatments for blood disorders. The journal will have a particular focus on providing a new avenue for researchers who may have resource constraints or face healthcare delivery challenges.
Dr. Jorge Cortes, director of the Georgia Cancer Center at Augusta University, will serve as the editor-in-chief of Blood Global Hematology, and will establish an international editorial board with representation from low- and middle-income countries. Dr. Cortes previously served as a professor of medicine at the University of Texas MD Anderson Cancer Center. He is chairman of the International Chronic Myeloid Leukemia Foundation, president of the Latin American Leukemia Net, and member of the International Steering Committee of the Japanese Society of Medical Oncology. He has been an associate editor for Blood and an active reviewer for other hematology journals.
To support authors from low- and middle-income countries, there will be no submission fees.
Blood Global Hematology will open for submissions in the fall 2024. The first articles will be published online in early 2025 and continuously thereafter.
Click here to read the original press release.
